Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-027784
Filing Date
2024-08-26
Accepted
2024-08-26 18:44:11
Documents
1
Period of Report
2024-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4154
  Complete submission text file 0001437749-24-027784.txt   5724
Mailing Address C/O FUEL SYSTEMS SOLUTIONS, INC. 780 THIRD AVE. 25TH FLOOR NEW YORK NY 10017
Business Address
BERSANI PIETRO (Reporting) CIK: 0001517309 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39619 | Film No.: 241242796

Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Issuer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)